ClearPoint Neuro, Inc.
Moat Score — ClearPoint Neuro, Inc.
Total Moat Score
10 / 30
| Moat Factor | Score | Analysis |
|---|---|---|
| Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. | 3 / 5 | ClearPoint holds device patents and a growing string of FDA clearances (including the 2024 SmartFrame OR system) that protect its specific navigation and delivery technology, though the broader neurosurgical navigation category is not exclusively its own. |
| Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. | 0 / 5 | As a small commercial-stage company, ClearPoint has no manufacturing or purchasing scale advantage versus giants like Medtronic, Boston Scientific, and Abbott. |
| Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. | 2 / 5 | Pricing reusable hardware competitively to win installations while capturing margin on disposables gives ClearPoint some pricing power over its installed base, though overall pricing is constrained by much larger, better-resourced competitors in adjacent categories. |
| Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. | 1 / 5 | As more pharmaceutical partners standardize on ClearPoint's delivery platform for CNS gene and cell therapy trials, the company's expertise and validated technology become a more attractive default choice for new programs, though this is a mild ecosystem effect rather than a strong network effect. |
| Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. | 3 / 5 | Once a hospital installs the ClearPoint System and trains surgical staff on it, switching to a competing navigation platform requires new capital spending, retraining, and workflow changes, creating real recurring-disposable lock-in. |
| Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. | 1 / 5 | MRI-guided neurosurgical navigation is a specialized, relatively small niche, which somewhat limits the number of viable competitors, but it has not stopped much larger medtech companies from also operating in adjacent segments. |